| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.08. | NEXGEL appoints Brian Kieser as interim CEO after Adam Levy steps down | 1 | Seeking Alpha | ||
| 20.08. | NEXGEL, INC. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 19.08. | NEXGEL Recalls SilverSeal From Amazon To Launch Product Into Higher-Margin Hospital Market | 5 | pulse2.com | ||
| NEXGEL Aktie jetzt für 0€ handeln | |||||
| 17.08. | NEXGEL reports Q2 results | 2 | Seeking Alpha | ||
| 17.08. | NEXGEL, INC. - 8-K, Current Report | 6 | SEC Filings | ||
| 29.07. | NEXGEL, INC. - 8-K, Current Report | 4 | SEC Filings | ||
| 02.07. | NEXGEL, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 17.06. | NEXGEL, INC. - 8-K, Current Report | 4 | SEC Filings | ||
| 19.05. | Nexgel hydrogel patch reduces laser plume in hair removal study | 8 | Investing.com | ||
| 19.05. | NEXGEL, INC.: NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration | 1 | GlobeNewswire (USA) | ||
| 15.05. | Earnings Call zu Q1 2026: Nexgel meldet Umsatzrückgang, Aktie gibt nach | 2 | Investing.com Deutsch | ||
| 15.05. | NexGel Q1 2026 Earnings Call Transcript | 2 | Benzinga.com | ||
| 15.05. | NEXGEL GAAP EPS of -$0.11 misses by $0.04, revenue of $2.65M misses by $1.26M | 1 | Seeking Alpha | ||
| 14.05. | NEXGEL, INC. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 13.05. | NEXGEL, INC.: NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical | 1 | GlobeNewswire (USA) | ||
| 12.05. | NEXGEL, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.05. | NEXGEL, INC.: NEXGEL To Report First Quarter 2026 Financial Results on May 15th | 2 | GlobeNewswire (USA) | ||
| 06.05. | NEXGEL, INC.: NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience, to Board of Directors | 2 | GlobeNewswire (USA) | ||
| 30.04. | NEXGEL, INC. - 10-K/A, Annual Report | 1 | SEC Filings | ||
| 30.04. | NEXGEL, INC. - 8-K, Current Report | 11 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BICO GROUP | 1,880 | -0,42 % | BICO-Preisnews: Anstieg um 10,09% innerhalb von 60 Minuten | ||
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | Nugen Medical Devices Inc: Nugen issues corrective disclosure following OSC review | ||
| SPINEWAY | 0,115 | 0,00 % | Spineway: H1 2026 results | H1 2026 results Continued growth Stable resultsStrong embedded growth driversIssuance of straight bonds to finance future growth In thousands of eurosConsolidated financial statements - UnauditedH1... ► Artikel lesen | |
| PING AN HEALTHCARE | 0,697 | 0,00 % | PA GOODDOCTOR (01833): 2026 INTERIM REPORT | ||
| ORGANON | 11,840 | -0,34 % | Dividendenbekanntmachungen (14.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADM HAMBURG AG DE0007269003 - 13,58 EUR AGCO CORPORATION US0010841023 0,3 USD 0,2602 EUR AGNT INC US30212W1009 0,05 USD 0,0433... ► Artikel lesen | |
| QUIDELORTHO | 12,645 | 0,00 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VIROMED MEDICAL | 6,500 | +2,36 % | EQS-News: Viromed Medical AG: Weitere Umplatzierungen aus dem Besitz des Vorstands und Gründers sollen die zusätzliche Finanzierung des laufenden Geschäftsbetriebs unterstützen | EQS-News: Viromed Medical AG
/ Schlagwort(e): Sonstiges
Viromed Medical AG: Weitere Umplatzierungen aus dem Besitz des Vorstands und Gründers sollen die zusätzliche Finanzierung... ► Artikel lesen | |
| CLARIANE | 3,880 | 0,00 % | Clariane: First-half 2026 results | Half-Year Results: strong improvement in operating performanceSuccessful refinancing transactions Objectives confirmed Strong improvement in operating performance Revenue as at 30 June 2026 stood... ► Artikel lesen | |
| NANO-X IMAGING | 0,832 | +0,23 % | Nano-X Imaging Ltd: Nanox to Report Second Quarter 2026 Financial Results on September 9, 2026 | ||
| PERSPECTIVE THERAPEUTICS | 2,726 | +2,02 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Provides Recent Business Highlights and Reports 2Q 2026 Results | Advancing VMT-a-NET toward a Phase 3 study in neuroendocrine tumors, subject to regulatory alignment: regulatory engagement ongoing; clinical site activation targeted around year-end 2026 subject... ► Artikel lesen | |
| ROCKWELL MEDICAL | 8,170 | 0,00 % | XFRA RWM: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILROCKWELL MEDICAL... ► Artikel lesen | |
| TEMPRAMED TECHNOLOGIES | 0,240 | +10,60 % | TempraMed Technologies Ltd.: TempraMed Signs Definitive Five-Year Saudi Arabia Distribution Agreement for Private-Label VIVI Cap | HighlightsFive-year definitive agreement with approximately US$3.8 million in potential minimum purchase commitments, beginning with a firm 10,000-unit initial purchase order.Agreement covers a... ► Artikel lesen | |
| NUWELLIS, INC | 0,870 | -2,12 % | Nuwellis, Inc. - 8-K, Current Report | ||
| HERAMED | 0,019 | 0,00 % | HERAMED LIMITED: Appendix 4D and Half Year Report | ||
| PROCEPT BIOROBOTICS | 20,850 | +0,10 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen |